<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400099</url>
  </required_header>
  <id_info>
    <org_study_id>UCSC-2015</org_study_id>
    <nct_id>NCT02400099</nct_id>
  </id_info>
  <brief_title>Protein-rich Diet and NAFLD in Bariatric Surgery</brief_title>
  <official_title>Protein-rich Diet and Non-Alcoholic Fatty Liver Disease in Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <brief_summary>
    <textblock>
      Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more
      effective than a control low calorie diet in improving the metabolic and histologic
      abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver fat content assessment</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity assessment</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fat free mass assessment</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity</condition>
  <condition>Non-alcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>900 Kcal; Protein 90 g (39%); CHO 75 g (30%); Lipid 32 g (31%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>900 Kcal; Protein. 50 g (22%); CHO 119 g (48%); Lipid 31 g (30%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High-protein low calorie diet</intervention_name>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control low calorie diet</intervention_name>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anthropometrical measurements</intervention_name>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body composition</intervention_name>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>8-h metabolic profile</intervention_name>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liver biopsy</intervention_name>
    <arm_group_label>High-protein low calorie diet (HPLC)</arm_group_label>
    <arm_group_label>Control low calorie diet (CLC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Morbidly obese subjects with a BMI &gt;40 kg/m2 who are eligible for bariatric surgery
             and have accepted to undergo RYGB

          -  Weight stable for at least 6 months before the study (+/- 5 kg within the previous 6
             months)

          -  Stable medication

          -  Provision of informed consent

        Exclusion Criteria:

          -  Patients not eligible for laparoscopic RYGB

          -  Incapacity to give a valid informed consent or unwilling to give the consent

          -  Pregnancy or lactating

          -  Type 2-diabetes mellitus

          -  Significant illness within the two weeks preceding surgery, as judged by the
             physician.

          -  Obvious infection (bacteria, virus etc)

          -  Major cardiovascular disease

          -  Major gastrointestinal, respiratory, or any hormonal disorders

          -  History of drug addiction and/or alcohol use

          -  Suspected or confirmed poor compliance

          -  Alcohol consumption of &gt; 20 g per day in the case of women and &gt; 30 g per day in the
             case of men for at least 3 consecutive months during the previous 5 years

          -  Presence of hepatitis C or frank cirrhosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Geltrude Mingrone, Professor</last_name>
    <phone>0630154395</phone>
    <phone_ext>0039</phone_ext>
    <email>gmingrone@rm.unicatt.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Catholic University School of Medicine</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2015</study_first_posted>
  <last_update_submitted>March 23, 2015</last_update_submitted>
  <last_update_submitted_qc>March 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Geltrude Mingrone</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

